The Board Nominating Committee, chaired by former president, Gregory Downey, MD, ATSF, FRCP(C), conducted a rigorous vetting of ATS members who responded to the call for nominations. The vetting process included submission of a letter of interest, written responses to specific questions, letters of support, virtual interview, feedback from colleagues and committee members, and input from staff. The committee also evaluated the candidates based on the competency framework - Leadership/Strategy, Financial Acumen, Innovative Thinking, Engagement and ensuring overall Diversity and Cultural Fit.

This year, there was an exceptional pool of applicants, as you can imagine this was not a simple task. In accordance with the recently amended bylaws, the ATS Board of Directors will consist of 15 at-large directors, one public member (Public Advisory Roundtable) who will serve staggered terms, and the CEO as an ex-officio, non-voting member. We are pleased to present the following slate for your consideration.